SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Full Disclosure Trading
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam Citron who wrote (9018)6/5/2004 12:48:13 PM
From: Carl Worth  Read Replies (1) of 13403
 
the estimates for RDY are .91 this year vs. .97 last year and then down to .87 next year, after their most recent earnings disappointment

i had looked at it a while back when it was mentioned on CNBC, as i think generic drugs in general should be a good area with the population demographics and such, but the fundamental picture just seems to be getting worse over time

do you see a catalyst to improve the outlook further out than next year?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News